E&L Failure at stability pull: sampling, filtration, and EM controls


Published on 29/12/2025

Investigating E&L Failures During Stability Pulls: A Practical Guide

In pharmaceutical manufacturing, especially when dealing with ophthalmic dosage forms, extracting the appropriate product for stability pulls is crucial to ensure quality and efficacy. However, the detection of extractables and leachables (E&L) failures during these pulls can pose significant risks to product integrity and compliance with Good Manufacturing Practices (GMP). This article outlines a structured investigation approach to identify and resolve E&L failure cases.

Upon reading this article, professionals will be equipped to effectively diagnose E&L issues stemming from stability pulls. The key focus will be on practical problem-solving steps, determining potential causes, and establishing corrective and preventive actions (CAPA) while ensuring compliance with FDA, EMA, and MHRA regulations.

Symptoms/Signals on the Floor or in the Lab

E&L failures can manifest in a multitude of ways during stability pulls. Awareness of the signs can facilitate early detection and prompt action. Common symptoms include:

  • Sensory evaluation: Unusual changes in color, odor, or clarity of the sample.
  • Chemical testing results: Out-of-specification (OOS)
findings in testing results pertaining to purity or content uniformity.
  • Error reports: Documentation of unexpected findings in batch records or deviations reported by laboratory personnel.
  • Microbial contamination: Presence of microbial growth during environmental monitoring (EM) assessments.
  • Device performance issues: Instrumental failures in analytical assessments, indicated by anomalous device readings.
  • Identifying these signals promptly enables the investigation to begin at the earliest opportunity, minimizing the risk of broader quality impacts.

    Likely Causes

    Identifying the root causes of E&L failures can be categorized into several dimensions: Materials, Method, Machine, Man, Measurement, and Environment (the 6 M’s).

    Materials:
    Assess sourcing and quality of raw materials, containers, and product contact surfaces. Incompatibilities or material degradation over time may contribute to E&L failures.

    Method:
    Examine the methodologies used during stability testing including sampling protocols and the filtration process, as improper techniques can introduce contaminants.

    Machine:
    Evaluate the equipment used for production and testing. Equipment malfunction or inadequacies in maintenance may play a role in failure occurrences.

    Man:
    Investigate human factors, including training and adherence to SOPs. Inadequate training or lapses in protocol execution can result in deviations.

    Measurement:
    Consider the validity of analytical methods used for testing E&L. Inaccurate measurements due to inappropriate calibration or lack of method validation could lead to errors.

    Environment:
    Analyze the environmental controls during stability testing, including temperature and humidity levels. Fluctuations in these parameters can compromise product integrity.

    Understanding the causes across these six categories can greatly enhance the thoroughness of the investigation.

    Immediate Containment Actions (first 60 minutes)

    When an E&L failure signal is detected, immediate actions are crucial to contain and mitigate risk. The first 60 minutes should focus on:

    1. **Isolation of Affected Samples:** Remove affected test samples from distribution or testing areas to prevent further use.

    2. **Notification of Relevant Personnel:** Alert quality control, quality assurance, and relevant management personnel about the deviation.

    3. **Securing Records:** Ensure that all related batch records, stability data, and environmental monitoring logs are preserved and secured, serving as vital evidence.

    4. **Initiation of a Deviation Investigation:** Document the initial findings, including the nature of the failure and the individuals involved in the sampling process.

    5. **Implementation of Additional Monitoring:** Increase monitoring measures at the stability testing locations for potential airborne contamination or environmental deviations.

    By taking these steps, organizations can not only address immediate risks but also organize an effective response.

    Investigation Workflow (data to collect + how to interpret)

    An effective investigation requires structured organization to collect and analyze relevant data systematically. The investigation workflow should include the collection of the following:

    1. **Batch Records:** Review batch production records associated with the E&L failure for any discrepancies in procedures.

    2. **Analytical Data:** Gather all analytical test results from stability pulls and evaluate trends or anomalies in the data.

    3. **Environmental Monitoring Results:** Look into EM records taken during the stability period, focusing on air quality, temperature, and humidity documents.

    4. **Samples from Other Batches:** If available, test samples from previous and subsequent batches to determine if the issue is batch-specific or systemic.

    5. **Operator Interviews:** Collect insights from personnel involved during the sampling and testing phases to ascertain procedural adherence.

    The analysis of the collected data should focus on:
    – Trend analysis to identify patterns in failures.
    – Comparative analysis against established acceptance criteria.
    – Identification of potential correlations between different variables.

    This thorough approach forms the backbone of the investigation to establish a comprehensive evidence base.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Once data is collected, it’s time to apply root cause analysis tools. The choice of tool will depend on the complexity of the issue and the information gathered.

    5-Why Analysis: This tool is effective for simple problems where asking “why” five times can expose underlying causes. It’s an intuitive approach that forces a deeper understanding of the failure.

    Fishbone Diagram (Ishikawa): Ideal for categorizing causes along the 6 M’s, the Fishbone diagram allows teams to visualize potential sources of failure and associate them with specific failure modes.

    Fault Tree Analysis (FTA): Best suited for more complex systems, the FTA enables a structured and quantitative approach to identifying root causes based on logical relationships between failure events, providing a detailed breakdown of reasons leading to failure.

    Applying these tools methodically will clarify pathways and identify genuine root causes.

    CAPA Strategy (correction, corrective action, preventive action)

    Once the root cause is identified, the next steps involve implementing a CAPA strategy encompassing three core elements:

    Correction: Implement immediate fixes to the identified issue. For E&L failures, this might involve quarantining impacted batches and recalling any distributed products.

    Corrective Action: After short-term corrections, develop and put in place long-term corrective measures. This could involve revising sampling protocols, upgrading equipment, or additional training for personnel.

    Preventive Action: Lastly, build robustness into the process to prevent recurrence. This may involve ongoing training sessions, regular maintenance and calibration of equipment, and enhanced monitoring of stability conditions.

    Document the entire CAPA process to ensure compliance and provide a basis for future reference during inspections.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    Implementing a robust control strategy is vital for detecting any future E&L failures proactively. The strategy should include:

    1. **Statistical Process Control (SPC):** Use SPC charts to track stability data trends over time for early signal detection.

    2. **Increased Frequency of Sampling:** Modify the frequency of both stability pulls and environmental monitoring to better capture variations early.

    3. **Installation of Alarms:** Introduce alarms or notifications for out-of-spec results or deviations detected during stability pull testing.

    4. **Ongoing Verification:** Regularly validate the sampling and testing processes against current best practices and regulatory guidelines to ensure continued efficacy.

    A well-documented control strategy will significantly enhance the preventive measures in place.

    Validation / Re-qualification / Change Control impact (when needed)

    In certain cases, E&L failures might trigger the need for validation re-qualification or change control processes. The following circumstances should be evaluated:

    1. **Change in Materials:** If a material encapsulates or interacts negatively with stability samples, initiate a change control to evaluate the material’s impact and requirements for re-validation.

    2. **Modification of Processes:** Any change in methods, particularly for E&L testing, may warrant a review to ensure compliance with regulatory standards.

    3. **Equipment Failures:** Incompatibilities or failures relating to equipment may necessitate validation protocols to confirm that modifications do not negatively affect the results.

    Working closely with regulatory partners from FDA, EMA, or MHRA throughout this evaluation will ensure compliance with requisite guidelines.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Being prepared for regulatory inspections is paramount, especially after an E&L failure incident. Key areas of focus should include:

    – **Deviation Reports:** Maintain comprehensive documentation of all deviations related to E&L failures, including the investigation outcomes and CAPA actions taken.

    – **Batch Record Logs:** Ensure all batch documentation is readily accessible, detailing every stage of production and testing.

    – **Environmental Monitoring Logs:** Provide evidence of EM control measures taken during stability testing, as well as any anomalies noted.

    – **Training Records:** Keep training documents attesting to staff competency with respect to relevant SOPs and operational requirements.

    A well-structured filing and documentation system will ensure rapid access to critical information during inspections.

    FAQs

    What is E&L failure?

    E&L failure refers to the presence of undesired extractables or leachables from packaging or delivery systems affecting the quality of pharmaceutical products.

    How can I identify symptoms of E&L failure?

    Symptoms can include unexpected product changes, OOS testing results, and irregular microbial testing results.

    What immediate actions should I take if E&L failure is suspected?

    Isolate affected samples, notify relevant personnel, and secure accompanying records quickly.

    What root cause analysis tools are effective for E&L investigations?

    Tools like 5-Why, Fishbone diagrams, and Fault Tree Analysis can help identify the root causes behind the E&L failure.

    Is CAPA critical for resolving E&L failure?

    Absolutely. A comprehensive CAPA strategy is essential for correcting the immediate issue and preventing future occurrences.

    How does change control impact E&L investigations?

    Change control helps assess any alterations in processes or materials that could affect product quality and ensures compliance with regulatory standards.

    What documents are critical for inspection readiness post-E&L failure?

    Deviation reports, batch records, environmental monitoring logs, and training records are all essential for compliance verification.

    What is the role of environmental monitoring in preventing E&L failures?

    Environmental monitoring helps identify potential contamination sources during stability pulls, facilitating early intervention.

    How do I ensure my team is prepared for E&L issue management?

    Regular training, standard operating procedures, and routine assessments of skills can help ensure that personnel are prepared for effective E&L issue management.

    Why is validation important in this context?

    Validation of methods and materials is crucial to ensure that the processes remain compliant with GMP and regulatory requirements, thus reducing the risk of E&L failures.

    How can SPC be implemented for E&L monitoring?

    Utilizing control charts and tracking stability data trends over time helps proactively identify deviations and potential E&L failure signals.


    Related Reads

    Pharma Tip:  Sterility Test Failure during aseptic filling: FDA-ready investigation report and batch disposition